Holdings of T. Rowe Price Health Sciences Portfolio
T. ROWE PRICE EQUITY SERIES, INC. · Original filing · Compare with another fund · Report an error
- Net assets
- 662.6M $ including 625.9M $ in equities, 94.5 %
- Positions
- 168 in 13 countries
- Bond lines
- 1 from 1 company
- Top ten
- 39.7 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Bicara Therapeutics Inc | 41,599 | 827.4K $ | 0.12 % |
| 102 | Tango Therapeutics Inc | 38,900 | 813.8K $ | 0.12 % |
| 103 | Relay Therapeutics Inc | 80,419 | 800.2K $ | 0.12 % |
| 104 | Cogent Biosciences Inc | 20,611 | 793.3K $ | 0.12 % |
| 105 | Repligen Corp | 6,705 | 790K $ | 0.12 % |
| 106 | Viatris Inc | 58,200 | 786.3K $ | 0.12 % |
| 107 | Tarsus Pharmaceuticals Inc | 11,077 | 777.1K $ | 0.12 % |
| 108 | Ocular Therapeutix Inc | 89,400 | 757.2K $ | 0.11 % |
| 109 | Molina Healthcare Inc | 5,556 | 740.6K $ | 0.11 % |
| 110 | Replimune Group Inc | 96,267 | 736.4K $ | 0.11 % |
| 111 | Disc Medicine Inc | 11,423 | 730.4K $ | 0.11 % |
| 112 | Tyra Biosciences Inc | 18,800 | 720K $ | 0.11 % |
| 113 | Corvus Pharmaceuticals Inc | 48,764 | 713.4K $ | 0.11 % |
| 114 | Kyverna Therapeutics Inc | 80,673 | 696.2K $ | 0.11 % |
| 115 | Medpace Holdings Inc | 1,400 | 672.3K $ | 0.10 % |
| 116 | Biohaven Ltd | 78,093 | 660.7K $ | 0.10 % |
| 117 | Climb Bio Inc | 93,200 | 638.4K $ | 0.10 % |
| 118 | Cullinan Therapeutics Inc | 42,900 | 609.6K $ | 0.09 % |
| 119 | Olema Pharmaceuticals Inc | 40,697 | 606.8K $ | 0.09 % |
| 120 | Liquidia Corp | 15,854 | 598.3K $ | 0.09 % |
| 121 | Allogene Therapeutics Inc | 243,268 | 593.6K $ | 0.09 % |
| 122 | Ideaya Biosciences Inc | 17,571 | 585.5K $ | 0.09 % |
| 123 | Pharvaris NV | 20,584 | 581.5K $ | 0.09 % |
| 124 | Lantheus Holdings Inc | 7,500 | 568.9K $ | 0.09 % |
| 125 | Denali Therapeutics Inc | 29,350 | 563.5K $ | 0.09 % |
| 126 | Atrium Therapeutics Inc | 41,700 | 557.5K $ | 0.08 % |
| 127 | Shattuck Labs Inc | 85,500 | 549.8K $ | 0.08 % |
| 128 | SENSORION SA | 1,029,513 | 488.8K $ | 0.07 % |
| 129 | SpyGlass Pharma Inc | 17,450 | 452.1K $ | 0.07 % |
| 130 | Iovance Biotherapeutics Inc | 127,849 | 448.7K $ | 0.07 % |
| 131 | PROCEPT BIOROBOTICS CORP | 17,941 | 448.7K $ | 0.07 % |
| 132 | Viridian Therapeutics Inc | 20,932 | 409.4K $ | 0.06 % |
| 133 | IMMATICS NV | 38,500 | 378.8K $ | 0.06 % |
| 134 | Evommune Inc | 16,349 | 375.9K $ | 0.06 % |
| 135 | Inspire Medical Systems Inc | 7,200 | 371.4K $ | 0.06 % |
| 136 | Alto Neuroscience Inc | 16,400 | 368.7K $ | 0.06 % |
| 137 | Aktis Oncology Inc | 20,013 | 358K $ | 0.05 % |
| 138 | CRESCENT BIOPHARMA INC | 17,631 | 323.9K $ | 0.05 % |
| 139 | Bicycle Therapeutics PLC | 62,846 | 291.6K $ | 0.04 % |
| 140 | Xencor Inc | 22,853 | 275.6K $ | 0.04 % |
| 141 | Immuneering Corp | 51,854 | 273.3K $ | 0.04 % |
| 142 | ZAI LAB LTD | 13,777 | 259.1K $ | 0.04 % |
| 143 | Entrada Therapeutics Inc | 20,159 | 254.4K $ | 0.04 % |
| 144 | Tectonic Therapeutic Inc | 7,600 | 234.9K $ | 0.04 % |
| 145 | Eikon Therapeutics Inc | 20,976 | 221.9K $ | 0.03 % |
| 146 | Generate Biomedicines Inc | 16,043 | 200.5K $ | 0.03 % |
| 147 | BridgeBio Oncology Therapeutics Inc | 21,253 | 190.2K $ | 0.03 % |
| 148 | Immix Biopharma Inc | 20,000 | 182.2K $ | 0.03 % |
| 149 | Agios Pharmaceuticals Inc | 4,357 | 147.4K $ | 0.02 % |
| 150 | Hims & Hers Health Inc | 6,500 | 134.9K $ | 0.02 % |
| 151 | SALUDA MEDICAL INC | 234,087 | 134.6K $ | 0.02 % |
| 152 | Aura Biosciences Inc | 20,070 | 134.3K $ | 0.02 % |
| 153 | Rocket Pharmaceuticals Inc | 36,464 | 130.5K $ | 0.02 % |
| 154 | Enliven Therapeutics Inc | 3,300 | 129.4K $ | 0.02 % |
| 155 | Immunovant Inc | 5,100 | 126.7K $ | 0.02 % |
| 156 | Monopar Therapeutics Inc | 2,185 | 119.7K $ | 0.02 % |
| 157 | Cabaletta Bio Inc | 44,485 | 119.7K $ | 0.02 % |
| 158 | Annexon Inc | 20,477 | 113.4K $ | 0.02 % |
| 159 | Adlai Nortye Ltd. | 13,419 | 92.9K $ | 0.01 % |
| 160 | LENZ Therapeutics Inc | 10,126 | 92.7K $ | 0.01 % |
| 161 | Beta Bionics Inc | 7,112 | 71.3K $ | 0.01 % |
| 162 | RadNet Inc | 1,116 | 62.4K $ | 0.01 % |
| 163 | MediWound Ltd | 3,812 | 61.4K $ | 0.01 % |
| 164 | Nuvation Bio Inc | 11,423 | 49K $ | 0.01 % |
| 165 | Janux Therapeutics Inc | 2,205 | 30.6K $ | 0.00 % |
| 166 | REVOLUTION MEDICINES INC WTS 12/26 | 11,096 | 19.3K $ | 0.00 % |
| 167 | Ginkgo Bioworks Holdings Inc | 2,281 | 14K $ | 0.00 % |
| 168 | GENEDX HOLDINGS CORP WTS 7/26 | 11,396 | 91.2 $ |
The bonds it holds
1 company, one bond line. Only issuers whose shares this site already serves appear here.
| Rank | Company | Bond lines | Value | Weight |
|---|---|---|---|---|
| 1 | Immunocore Holdings PLC | 1 | 666.2K $ | 0.10 % |
Sector breakdown
- Health care 68.4 %
- Unattributed 31.6 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.8 %
- HKD 1.3 %
- JPY 0.6 %
- CHF 0.2 %
- EUR 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- United States 88.4 %
- United Kingdom 3.4 %
- Netherlands 3.3 %
- Bermuda 1.4 %
- Hong Kong SAR China 1.3 %
- Japan 0.6 %
- Cayman Islands 0.5 %
- France 0.5 %
- Switzerland 0.2 %
- Denmark 0.2 %
- Singapore 0.1 %
- British Virgin Islands 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 148 | 553.1M $ | 88.37 % |
| 2 | United Kingdom | 2 | 21.3M $ | 3.41 % |
| 3 | Netherlands | 3 | 20.4M $ | 3.25 % |
| 4 | Bermuda | 2 | 8.5M $ | 1.36 % |
| 5 | Hong Kong SAR China | 1 | 8M $ | 1.28 % |
| 6 | Japan | 1 | 3.9M $ | 0.62 % |
| 7 | Cayman Islands | 4 | 3.4M $ | 0.54 % |
| 8 | France | 2 | 3.3M $ | 0.52 % |
| 9 | Switzerland | 1 | 1.5M $ | 0.24 % |
| 10 | Denmark | 1 | 1M $ | 0.16 % |
| 11 | Singapore | 1 | 931.8K $ | 0.15 % |
| 12 | British Virgin Islands | 1 | 660.7K $ | 0.11 % |
Cite this page
Titelia. "Holdings of T. Rowe Price Health Sciences Portfolio". https://titelia.com/en/funds/S000002083